Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

OBJECTIVES: To explore the epidemiological information, clinical characteristics, therapeutic outcomes and temporal progression of laboratory findings in 2019-coronavirus disease (COVID-19) patients exposed to lopinavir. METHODS: We collected data from ten COVID-19 patients admitted between January...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Xu, Aifang, Zhang, Yan, Xuan, Weiling, Yan, Tingbo, Pan, Kenv, Yu, Wenyan, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193136/
https://www.ncbi.nlm.nih.gov/pubmed/32173576
http://dx.doi.org/10.1016/j.ijid.2020.03.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193136/
https://www.ncbi.nlm.nih.gov/pubmed/32173576
http://dx.doi.org/10.1016/j.ijid.2020.03.013

Ejemplares similares